Walgreens Nasal Spray Recall
Analysis based on 6 articles · First reported Nov 25, 2025 · Last updated Dec 06, 2025
The recall by Walgreens of its Saline Nasal Spray due to bacterial contamination could lead to a minor negative impact on Walgreens' brand reputation and potentially affect sales of its private-label health products. The United States — Food and Drug Administration's classification of the recall as Class II suggests that while the health consequences are temporary, it highlights the importance of product safety in the pharmaceutical and retail sectors.
Walgreens has issued a recall for over 41,000 bottles of its Saline Nasal Spray with Xylitol, sold nationwide, due to potential contamination with the microorganism Pseudomonas lactis. The United States — Food and Drug Administration classified this as a Class II recall, meaning the product's use may cause temporary or medically reversible adverse health consequences, particularly for individuals with weakened immune or respiratory systems. Consumers are advised to stop using the affected products, which include lot numbers 71409 and 71861, and return them to Walgreens for a full refund. This event occurs during the cold and flu season, a period of increased reliance on such products.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard